Icon

LOVAZA (nda021654)- (1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS)

OMEGA-3-ACID ETHYL ESTERS WOODWARD
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Yes No
2025-Jan-30 Expired
None None
None No
LOVAZA is a combination of ethyl esters of omega 3 fatty acids, principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia
13 0 10
Total Other Developers 1
Drugs with Suitability No
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS ** ** - 1 7
NDA Sales Available Total Generic Sales Available
No 8
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ***. *********** ** ******** ****., *********, ******* *** ***, ****** (***) ***
****** ****** ******** ******* ******* *********** **** ********** *****, *******, ******* *** ***, ****** (***) ***
****** *** ******* ******** ***. *********** **** ******* **, **** *****, ***** ******** (**) *****, ****** ****** (***) ***
****** ******* ****** ******* ****** ******* ******* *********** ** **/*,******************, ********* *****, ****** *****, *********, ********* ******, ***** (***) ***
****** ****** ****** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** ********* ******* ******** ***. *********** **** ******* **, **** *****, ***** ******** (**) *****, ****** ****** (***) ***
****** ****** ****** *** ****** *************** *** *********** *** * ********** **, ******* *****, *** **** (**) *****, ****** ****** (***) ***
****** ******* ***** *** ********* ******* *************** (*****) **., *** *********** **.**, *** ******* ****, **** **** *** ********** *********** ********, *****, ***** ******, ***** (***) ***
****** ****** ****** ******* * * *********** ***** ** ** * ***, ************, ********* , ******** (***) ***
****** ******* ****** ******* ********** ******* ******* *********** ****** **. **/*, ******** *********** ****, ********** *******, ***********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.